The discussions around modernizing the Dietary Supplement Health and Education Act (DSHEA) have included a proposal from FDA about developing a mandatory product listing. The agency has said such a listing could be implemented with minimal burden to industry, while the increased visibility into the market would significantly improve oversight and benefit consumers. If such a mandate is included in a so-called DSHEA 2.0 update, what would it mean for responsible supplement companies already following laws and regulations, as well as “bad actors” already disregarding similar requirements imposed on the supplement industry?

Host Josh Long taps three industry insiders to highlight their criticisms of a mandatory product listing,

For all episodes, including the previous episode in which two lawyers expressed their support for a mandatory product listing, visit the Short Legal Briefs show page.